During the past decade, Hillcrest Medical Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 7 clinical trials were completed, i.e. on average, 350% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hillcrest Medical Center" #1 sponsor was "Abbott Medical Devices" with 4 trials, followed by "Boston Scientific Corporation" with 3 trials sponsored, "Intuitive Surgical" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Biotronik, Inc." with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hillcrest Medical Center" #1 collaborator was "Accelovance" with 1 trials as a collaborator, "Baim Institute for Clinical Research" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Daiichi Sankyo, Inc." with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Hillcrest Medical Center" are "Coronary Artery Disease" (4 trials), "Coronary Artery Stenosis" (3 trials), "Coronary Disease" (3 trials), "Myocardial Ischemia" (3 trials) and "Coronary Restenosis" (2 trials). Many other conditions were trialed in "Hillcrest Medical Center" in a lesser frequency.

Most popular intervention types in "Hillcrest Medical Center" are "Device" (9 trials), "Procedure" (4 trials), "Drug" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "2.25 mm XIENCE V® Everolimus Eluting Coronary Stent System" (1 trials), "ABPM" (1 trials), "ACUITY Spiral Left Ventricular Lead" (1 trials), "AV Therapy Assessment-B301 investigational device" (1 trials) and "Absorb BVS" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hillcrest Medical Center" are 14 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hillcrest Medical Center". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Hillcrest Medical Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Hillcrest Medical Center, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 5 trials that are defined as “Not Applicable".